Arrhythmogenesis: a Roadblock to Cardiac Stem Cell Therapy

Yen Wen Liu, Chi Ting Su, Christopher Y.T. Yen, Li Jen Lin, Patrick C.H. Hsieh

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)


Despite significant advances in the treatment of ischemic heart disease (IHD), it remains the leading cause of mortality worldwide. Undoubtedly, methods for regenerating the injured human heart are urgently needed, and whilst exciting progress has been made from utilizing stem cell therapy for cardiac regeneration, several major challenges still remain. In particular, one major safety issue is the occurrence of potentially life-threatening ventricular arrhythmias after cell therapy. Several drivers may be responsible for this, ranging from the potential inherent arrhythmogenicity of delivered stem cells to that of the underlying IHD. Therefore, it is imperative to thoroughly assess the risk-to-benefit ratio of such treatments prior to the clinical application. As such, despite the considerable progress made in stem cell therapy over the past decades, many obstacles still lie ahead.

Original languageEnglish
Article number61
JournalCurrent Treatment Options in Cardiovascular Medicine
Issue number10
Publication statusPublished - 2016 Oct 1

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Arrhythmogenesis: a Roadblock to Cardiac Stem Cell Therapy'. Together they form a unique fingerprint.

Cite this